![STAT+: ‘This is an industry that everyone [bleeping] hates’](https://www.statnews.com/wp-content/uploads/2022/06/AdamsTake_Illustration_MollyFerguson_061322-1024x576.jpg?#)
.jpg)
Gene therapy CDMO Artis BioSolutions launches with acquisition of Landmark Bio
Artis BioSolutions marked its launch as a cell and gene therapy CDMO this week with the acquisition of personalized medicine compatriot Landmark Bio. Financial terms of the deal were not disclosed.
Artis BioSolutions marked its launch as a cell and gene therapy CDMO this week with the acquisition of personalized medicine compatriot Landmark Bio. Financial terms of the deal were not disclosed.
